Deniz Bagdas
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Deniz Bagdas has a total of 80 co-authors. Here are the top co-authors by number of shared publications:
Nii A. Addy
Department of Psychiatry, Yale School of Medicine, Yale University
5 shared publications- Nii A. Addy
Department of Psychiatry, Yale School of Medicine, New Haven, CT, USA; Department of Cellular and Molecular Physiology, Yale School of Medicine, New Haven, CT, USA; Wu Tsai Institute, Yale University, New Haven, CT, USA; Interdepartmental Neuroscience Program, Yale University, New Haven, CT, USA
4 shared publications Karina Minanov
Department of Psychiatry, Yale School of Medicine, Yale University
3 shared publicationsLilley Harris
Department of Psychiatry, Yale School of Medicine, New Haven, USA
3 shared publications- Mohamad Imad Damaj
Department of Pharmacology and Toxicology, Virginia Commonwealth University, USA
3 shared publications - Zulfiye Gul
Department of Medical Pharmacology, Faculty of Medicine, Bahcesehir University, Istanbul, Turkey
3 shared publications
Latest Publications
- Open Access
- 23 September 2026
- Published by Frontiers Media SA in Frontiers in Pharmacology
- Vol. 17, 1955253
The ratio of propylene glycol to glycerol modulates nicotine taste and reward: more glycerol, more reward
Background: Propylene glycol (PG) and glycerol (Gly) are odorless tobacco product constituents that act as solvents in electronic cigarette e-liquids and as humectants in oral nicotine products. Little is known about how PG/Gly ratio may affect nicotine’s sensory and rewarding properties. To address this gap, we utilized the taste reactivity test and four-bottle choice test to investigate the impact of PG/Gly ratio on nicotine’s taste and reward. Methods: A taste reactivity test was performed using young adult rats that received oral infusions of water, nicotine (10 μg/mL) and various PG/Gly ratios in the absence and presence of nicotine via intraoral catheters. Facial responses to each infusion were video recorded and the ingestive and aversive taste responses to each solution were scored and analyzed. In a separate cohort of rats, a four-bottle choice test was utilized to assess preference for various PG/Gly ratios with or without nicotine. Results: Young adult rats exhibited higher aversive reactions to PG100/Gly0 alone. Higher Gly content (PG0/Gly100 with nicotine) increased ingestive responses compared to nicotine alone. Higher Gly content (PG20/Gly80 with nicotine and PG0/Gly100 with nicotine) decreased aversive reactions compared to nicotine alone. Young adult rats also displayed greater preference for PG0/Gly100 alone and PG0/Gly100 with nicotine compared to vehicle water and nicotine, respectively. Conclusion: Overall, nicotine’s ingestive and aversive taste was altered by PG and Gly depending on the ratio. Specifically, higher Gly enhanced nicotine’s hedonic value and reduced nicotine’s aversive properties in both sexes. Higher Gly content was also preferred during the four-bottle choice test alone and in the presence of nicotine. Together, our results suggests that PG/Gly ratio, particularly high Gly content, influences nicotine’s abuse liability.
- 23 September 2026
- Published by Frontiers Media SA in Frontiers in Pharmacology
- Vol. 17, 1955253
Open AccessThe ratio of propylene glycol to glycerol modulates nicotine taste and reward: more glycerol, more reward
Background: Propylene glycol (PG) and glycerol (Gly) are odorless tobacco product constituents that act as solvents in electronic cigarette e-liquids and as humectants in oral nicotine products. Little is known about how PG/Gly ratio may affect nicotine’s sensory and rewarding properties. To address this gap, we utilized the taste reactivity test and four-bottle choice test to investigate the impact of PG/Gly ratio on nicotine’s taste and reward. Methods: A taste reactivity test was performed using young adult rats that received oral infusions of water, nicotine (10 μg/mL) and various PG/Gly ratios in the absence and presence of nicotine via intraoral catheters. Facial responses to each infusion were video recorded and the ingestive and aversive taste responses to each solution were scored and analyzed. In a separate cohort of rats, a four-bottle choice test was utilized to assess preference for various PG/Gly ratios with or without nicotine. Results: Young adult rats exhibited higher aversive reactions to PG100/Gly0 alone. Higher Gly content (PG0/Gly100 with nicotine) increased ingestive responses compared to nicotine alone. Higher Gly content (PG20/Gly80 with nicotine and PG0/Gly100 with nicotine) decreased aversive reactions compared to nicotine alone. Young adult rats also displayed greater preference for PG0/Gly100 alone and PG0/Gly100 with nicotine compared to vehicle water and nicotine, respectively. Conclusion: Overall, nicotine’s ingestive and aversive taste was altered by PG and Gly depending on the ratio. Specifically, higher Gly enhanced nicotine’s hedonic value and reduced nicotine’s aversive properties in both sexes. Higher Gly content was also preferred during the four-bottle choice test alone and in the presence of nicotine. Together, our results suggests that PG/Gly ratio, particularly high Gly content, influences nicotine’s abuse liability.
- Open Access
Chronic pain exacerbates nicotine withdrawal severity in a sex-specific and dose-dependent manner
Chronic pain and nicotine use frequently co-occur, and individuals with chronic pain often experience greater difficulty quitting. Therefore, we examined nicotine withdrawal behaviors and analgesic-like effects in pain-naive and chronic pain conditions. Adult male and female rats underwent chronic constriction injury or sham surgery. After pain establishment, rats received twice-daily subcutaneous nicotine (0.3 or 0.7 mg/kg) or saline for 14 days. 24 h after the final injection, withdrawal was assessed, including physical signs and anxiety-like behavior. Depressive-like responses were evaluated at 72 h. Pain sensitivity and nicotine’s analgesic-like effects were assessed throughout. Chronic pain increased physical signs of withdrawal in both sexes, with greater effects in females. It also induced anxiety-like behavior in controls of both sexes. In rats with comorbid chronic pain and withdrawal, anxiety-like behavior was further enhanced in males, whereas females showed variable responses across assays, with increases or decreases depending on the test. Chronic pain induced depressive-like behavior in males but not in females. During withdrawal, depressive-like responses in males with chronic pain were not greater than those in the chronic pain alone group, while chronic nicotine exposure reduced depressive-like behavior in females. Nicotine produced acute analgesic-like effects that diminished over time in both pain-naive and chronic pain conditions, indicating tolerance. In pain-naive rats, repeated nicotine exposure induced mechanical hypersensitivity. Chronic pain intensified nicotine withdrawal severity in a nicotine concentration- and sex-dependent manner. These findings highlight the importance of considering pain status and sex when developing effective cessation strategies, particularly for individuals with comorbid chronic pain. Summary: Chronic pain exacerbates nicotine withdrawal severity. Chronic nicotine exposure induces pain hypersensitivity and tolerance to analgesic effects. These effects vary by nicotine concentration and sex.
Open AccessChronic pain exacerbates nicotine withdrawal severity in a sex-specific and dose-dependent manner
Chronic pain and nicotine use frequently co-occur, and individuals with chronic pain often experience greater difficulty quitting. Therefore, we examined nicotine withdrawal behaviors and analgesic-like effects in pain-naive and chronic pain conditions. Adult male and female rats underwent chronic constriction injury or sham surgery. After pain establishment, rats received twice-daily subcutaneous nicotine (0.3 or 0.7 mg/kg) or saline for 14 days. 24 h after the final injection, withdrawal was assessed, including physical signs and anxiety-like behavior. Depressive-like responses were evaluated at 72 h. Pain sensitivity and nicotine’s analgesic-like effects were assessed throughout. Chronic pain increased physical signs of withdrawal in both sexes, with greater effects in females. It also induced anxiety-like behavior in controls of both sexes. In rats with comorbid chronic pain and withdrawal, anxiety-like behavior was further enhanced in males, whereas females showed variable responses across assays, with increases or decreases depending on the test. Chronic pain induced depressive-like behavior in males but not in females. During withdrawal, depressive-like responses in males with chronic pain were not greater than those in the chronic pain alone group, while chronic nicotine exposure reduced depressive-like behavior in females. Nicotine produced acute analgesic-like effects that diminished over time in both pain-naive and chronic pain conditions, indicating tolerance. In pain-naive rats, repeated nicotine exposure induced mechanical hypersensitivity. Chronic pain intensified nicotine withdrawal severity in a nicotine concentration- and sex-dependent manner. These findings highlight the importance of considering pain status and sex when developing effective cessation strategies, particularly for individuals with comorbid chronic pain. Summary: Chronic pain exacerbates nicotine withdrawal severity. Chronic nicotine exposure induces pain hypersensitivity and tolerance to analgesic effects. These effects vary by nicotine concentration and sex.
- Open Access
Cannabis Co-Use and Endocannabinoid System Modulation in Tobacco Use Disorder: A Translational Systematic Review and Meta-Analysis
Tobacco use disorder (TUD) remains a leading cause of preventable mortality, and existing pharmacotherapies yield 12-month abstinence rates below 30%. As cannabis legalization expands, approximately 18-22% of people who use tobacco report concurrent cannabis use, yet the impact of co-use on cessation outcomes and the therapeutic potential of endocannabinoid system (ECS) modulation remain unclear. We conducted a translational systematic review and meta-analysis following PRISMA 2020 guidelines, searching Ovid MEDLINE, Embase, APA PsycInfo, and Web of Science through January 2026 (PROSPERO: CRD420250652724). Three study categories were eligible: observational studies of cannabis co-use and cessation outcomes; preclinical studies of cannabinoid modulators on nicotine-related behaviors; and human experimental studies of ECS-targeted interventions. Of 4,869 records screened, 52 studies met inclusion criteria. Meta-analysis of 18 observational studies (N=229,630) revealed that cannabis use was associated with 35% lower odds of achieving tobacco cessation (OR=0.65; 95% CI: 0.55-0.78; p<0.0001; I²=88.1%). Preclinical evidence (15 studies) demonstrated that CB1 receptor antagonists robustly reduced nicotine self-administration and reinstatement, while cannabidiol (CBD) attenuated both nicotine intake and withdrawal without affecting food reinforcement. Clinical translation of CB1 receptor inverse agonists failed due to psychiatric adverse effects, but CBD showed promise by reducing cigarette consumption by 40%, reversing attentional bias to smoking cues, and alleviating withdrawal severity. These findings distinguish naturalistic cannabis exposure from potentially beneficial targeted ECS modulation, and support CBD as a promising candidate for adequately powered tobacco cessation trials.
Open AccessCannabis Co-Use and Endocannabinoid System Modulation in Tobacco Use Disorder: A Translational Systematic Review and Meta-Analysis
Tobacco use disorder (TUD) remains a leading cause of preventable mortality, and existing pharmacotherapies yield 12-month abstinence rates below 30%. As cannabis legalization expands, approximately 18-22% of people who use tobacco report concurrent cannabis use, yet the impact of co-use on cessation outcomes and the therapeutic potential of endocannabinoid system (ECS) modulation remain unclear. We conducted a translational systematic review and meta-analysis following PRISMA 2020 guidelines, searching Ovid MEDLINE, Embase, APA PsycInfo, and Web of Science through January 2026 (PROSPERO: CRD420250652724). Three study categories were eligible: observational studies of cannabis co-use and cessation outcomes; preclinical studies of cannabinoid modulators on nicotine-related behaviors; and human experimental studies of ECS-targeted interventions. Of 4,869 records screened, 52 studies met inclusion criteria. Meta-analysis of 18 observational studies (N=229,630) revealed that cannabis use was associated with 35% lower odds of achieving tobacco cessation (OR=0.65; 95% CI: 0.55-0.78; p<0.0001; I²=88.1%). Preclinical evidence (15 studies) demonstrated that CB1 receptor antagonists robustly reduced nicotine self-administration and reinstatement, while cannabidiol (CBD) attenuated both nicotine intake and withdrawal without affecting food reinforcement. Clinical translation of CB1 receptor inverse agonists failed due to psychiatric adverse effects, but CBD showed promise by reducing cigarette consumption by 40%, reversing attentional bias to smoking cues, and alleviating withdrawal severity. These findings distinguish naturalistic cannabis exposure from potentially beneficial targeted ECS modulation, and support CBD as a promising candidate for adequately powered tobacco cessation trials.
- Open Access
Effects of commercial unflavored and vanilla-flavored e-liquids on nicotine intake and withdrawal
Electronic cigarette liquids (e-liquids) often contain flavors and solvents that may influence nicotine addiction. In this study, we characterized the dose-response relationship of commercial unflavored nicotine e-liquids and investigated the impact of vanilla-flavored e-liquids on nicotine vapor self-administration (VSA) and withdrawal in rats. Male adolescent Sprague Dawley rats self-administered aerosols generated from commercial e-liquids containing 0, 3, 6, or 12 mg/ml nicotine in a propylene glycol (PG) and glycerol (G) vehicle. The vehicle (0 mg/ml nicotine) supported robust VSA, indicating the reinforcing effects of PG/G vapor. 3 mg/ml nicotine did not support VSA, while both 6 and 12 mg/ml nicotine concentrations produced significant reinforcement, with 6 mg/ml yielding the most stable responding. The 6 mg/ml concentration was selected for subsequent comparisons with vanilla-flavored e-liquids. Vanilla flavor (0 mg/ml nicotine) led to maintained VSA behavior, confirming its reinforcing effects. However, the combination of vanilla and nicotine (6 mg/ml) did not alter nicotine intake or withdrawal severity, as assessed by mecamylamine-precipitated somatic signs. Blood nicotine and cotinine levels were similar between nicotine and vanilla + nicotine conditions, indicating that vanilla flavor did not affect systemic nicotine metabolism. Additionally, the PG/G vehicle induced significant somatic signs, suggesting that vapor exposure itself, independent of nicotine, contributes to these physiological responses. These findings provide critical insights into the reinforcing and physiological effects of both nicotine and non-nicotine constituents in e-cigarette aerosols, underscoring the need for future studies and regulatory strategies that consider the abuse liability of flavors and solvents, such as PG/G, particularly among adolescents. Significance Statement: Flavored electronic nicotine delivery systems raise concern for promoting nicotine use in youth. Using a rat vapor self-administration model, we show nicotine produces concentration-dependent reinforcement, while vanilla flavor is reinforcing but does not enhance nicotine intake or withdrawal.
Open AccessEffects of commercial unflavored and vanilla-flavored e-liquids on nicotine intake and withdrawal
Electronic cigarette liquids (e-liquids) often contain flavors and solvents that may influence nicotine addiction. In this study, we characterized the dose-response relationship of commercial unflavored nicotine e-liquids and investigated the impact of vanilla-flavored e-liquids on nicotine vapor self-administration (VSA) and withdrawal in rats. Male adolescent Sprague Dawley rats self-administered aerosols generated from commercial e-liquids containing 0, 3, 6, or 12 mg/ml nicotine in a propylene glycol (PG) and glycerol (G) vehicle. The vehicle (0 mg/ml nicotine) supported robust VSA, indicating the reinforcing effects of PG/G vapor. 3 mg/ml nicotine did not support VSA, while both 6 and 12 mg/ml nicotine concentrations produced significant reinforcement, with 6 mg/ml yielding the most stable responding. The 6 mg/ml concentration was selected for subsequent comparisons with vanilla-flavored e-liquids. Vanilla flavor (0 mg/ml nicotine) led to maintained VSA behavior, confirming its reinforcing effects. However, the combination of vanilla and nicotine (6 mg/ml) did not alter nicotine intake or withdrawal severity, as assessed by mecamylamine-precipitated somatic signs. Blood nicotine and cotinine levels were similar between nicotine and vanilla + nicotine conditions, indicating that vanilla flavor did not affect systemic nicotine metabolism. Additionally, the PG/G vehicle induced significant somatic signs, suggesting that vapor exposure itself, independent of nicotine, contributes to these physiological responses. These findings provide critical insights into the reinforcing and physiological effects of both nicotine and non-nicotine constituents in e-cigarette aerosols, underscoring the need for future studies and regulatory strategies that consider the abuse liability of flavors and solvents, such as PG/G, particularly among adolescents. Significance Statement: Flavored electronic nicotine delivery systems raise concern for promoting nicotine use in youth. Using a rat vapor self-administration model, we show nicotine produces concentration-dependent reinforcement, while vanilla flavor is reinforcing but does not enhance nicotine intake or withdrawal.
- Open Access
- 28 October 2025
- Published by Oxford University Press (OUP) in Nicotine & Tobacco Research
- Vol. 28 (4) , 692-695
Integrating Pain Assessment in Nicotine and Tobacco Research and Treatment to Improve Cessation Outcomes
- 28 October 2025
- Published by Oxford University Press (OUP) in Nicotine & Tobacco Research
- Vol. 28 (4) , 692-695
Open AccessIntegrating Pain Assessment in Nicotine and Tobacco Research and Treatment to Improve Cessation Outcomes
- 18 March 2025
- Published by Oxford University Press (OUP) in Nicotine & Tobacco Research
- Vol. 28 (2) , 242-250
Effects of Sweeteners and Cinnamon Flavor on Oral Nicotine Choice Behaviors
Introduction: Oral nicotine products (ONPs) are emerging as a new nicotine delivery method, with varied types and flavors such as sweeteners and cinnamon. This study evaluates how sucrose, saccharin, and cinnamaldehyde influence nicotine preference, shedding light on the potential appeal of ONPs and how they may impact on harm reduction. Methods: For oral choice behavior studies, we utilized a four-bottle choice (BC) test in male and female adult Sprague-Dawley rats. We first examined most common sucrose (1%) and saccharin (0.32%) concentrations as sweet solutions, and quinine (0.01%) as a bitter solution, to determine 4BC sensitivity and ability to distinguish between sweet and bitter tastes. We then performed dose–response analyses with sucrose (0.01%, 0.1%, and 1%), saccharin (0.032%, 0.1%, and 0.32%), and cinnamaldehyde (0.0005%, 0.005%, and 0.05%), in comparison to water in 4BC. Lastly, we tested nicotine (10 µg/mL) choice behaviors in the presence of sweeteners and/or cinnamaldehyde. Results: Female and male rats significantly preferred sucrose (1%) and saccharin (0.1% and 0.32%) but not cinnamaldehyde. Moreover, rats differentiated sweet and bitter solutions with the highest preference for saccharin. Sucrose increased nicotine preference in females, but cinnamaldehyde increased nicotine preference in males. Saccharin increased nicotine preference in females, but not in males. Additionally, the combination of cinnamaldehyde and saccharin increased nicotine preference in females. Conclusions: We found differential preferences among the test solution concentrations with the highest sweetener concentrations being most preferred. Sweetness value of the nicotine solution played a major role on nicotine preference in females but not in males. Implications: Understanding how sweeteners and flavor additives affect oral nicotine choice behavior and nicotine preference in ONPs can guide the development of targeted harm reduction strategies and regulatory policies. By identifying which additives enhance product appeal and potentially influence addiction, this research can inform the creation of safer ONP formulations. This research also supports the utility of evidence-based guidelines for ONP use.
- 18 March 2025
- Published by Oxford University Press (OUP) in Nicotine & Tobacco Research
- Vol. 28 (2) , 242-250
Effects of Sweeteners and Cinnamon Flavor on Oral Nicotine Choice Behaviors
Introduction: Oral nicotine products (ONPs) are emerging as a new nicotine delivery method, with varied types and flavors such as sweeteners and cinnamon. This study evaluates how sucrose, saccharin, and cinnamaldehyde influence nicotine preference, shedding light on the potential appeal of ONPs and how they may impact on harm reduction. Methods: For oral choice behavior studies, we utilized a four-bottle choice (BC) test in male and female adult Sprague-Dawley rats. We first examined most common sucrose (1%) and saccharin (0.32%) concentrations as sweet solutions, and quinine (0.01%) as a bitter solution, to determine 4BC sensitivity and ability to distinguish between sweet and bitter tastes. We then performed dose–response analyses with sucrose (0.01%, 0.1%, and 1%), saccharin (0.032%, 0.1%, and 0.32%), and cinnamaldehyde (0.0005%, 0.005%, and 0.05%), in comparison to water in 4BC. Lastly, we tested nicotine (10 µg/mL) choice behaviors in the presence of sweeteners and/or cinnamaldehyde. Results: Female and male rats significantly preferred sucrose (1%) and saccharin (0.1% and 0.32%) but not cinnamaldehyde. Moreover, rats differentiated sweet and bitter solutions with the highest preference for saccharin. Sucrose increased nicotine preference in females, but cinnamaldehyde increased nicotine preference in males. Saccharin increased nicotine preference in females, but not in males. Additionally, the combination of cinnamaldehyde and saccharin increased nicotine preference in females. Conclusions: We found differential preferences among the test solution concentrations with the highest sweetener concentrations being most preferred. Sweetness value of the nicotine solution played a major role on nicotine preference in females but not in males. Implications: Understanding how sweeteners and flavor additives affect oral nicotine choice behavior and nicotine preference in ONPs can guide the development of targeted harm reduction strategies and regulatory policies. By identifying which additives enhance product appeal and potentially influence addiction, this research can inform the creation of safer ONP formulations. This research also supports the utility of evidence-based guidelines for ONP use.
- 16 October 2024
- Published by Oxford University Press (OUP) in Nicotine & Tobacco Research
- Vol. 27 (4) , 666-675
Preclinical Evidence of the Effects of Sweet Flavors: Sweetness Increases Nicotine Intake and Seeking
Introduction: The influence of early exposure to sweet and fruit flavors on subsequent nicotine use behaviors during adolescence remains poorly understood. To address this gap, we utilized a rodent model to simulate childhood flavor exposure and examine its effects on later nicotine use behaviors. Aims and Methods: We employed a two-bottle choice paradigm in weanling rats to mimic human childhood flavor exposure. Subsequently, we investigated the impact of early exposure to sweet (saccharin) and cherry fruit (benzaldehyde) flavors on adolescent nicotine use behaviors. This included assessing subsequent nicotine acquisition, maintenance, and seeking behaviors using intraoral flavor and intravenous nicotine self-administration. Results: Our findings reveal that rats exposed to saccharin during early development exhibited altered patterns of nicotine intake and seeking behaviors during adolescence. Specifically, rats demonstrated increased nicotine intake and seeking of saccharin flavored solutions when paired with nicotine, indicating a potential predisposition towards nicotine use following childhood flavor exposure. Intraoral benzaldehyde did not affect nicotine reinforcement in early sessions of self-administration, but significantly decreased nicotine reinforcement during later sessions. Both saccharin exposure alone or in combination with benzaldehyde promoted nicotine reinforcement. No significant sex differences in nicotine-related behaviors were observed. Conclusions: This study highlights the significance of early flavor exposure in shaping adolescent nicotine use behaviors. The findings suggest that childhood exposure to sweet flavors may contribute to heightened susceptibility to nicotine use and addiction later in life. Understanding these early influences is crucial for developing targeted interventions to prevent the onset of nicotine addiction during adolescence. Implications: Our study highlights the importance of how sweetness can contribute to and possibly even alter the effects of the flavor itself. The sweetness of a tobacco product does not solely stem from sweeteners, but it is also influenced by other components such as the propylene glycol (PG) and vegetable glycerin (VG) ratio (eg, higher VG) and the inclusion of flavors associated with sweetness (eg, vanillin and ethyl maltol). Therefore, sweet-associated constituents in tobacco products should be investigated further to inform regulatory policy. We believe that our findings can inform regulatory decisions on controlling sweet-associated constituents in tobacco products.
- 16 October 2024
- Published by Oxford University Press (OUP) in Nicotine & Tobacco Research
- Vol. 27 (4) , 666-675
Preclinical Evidence of the Effects of Sweet Flavors: Sweetness Increases Nicotine Intake and Seeking
Introduction: The influence of early exposure to sweet and fruit flavors on subsequent nicotine use behaviors during adolescence remains poorly understood. To address this gap, we utilized a rodent model to simulate childhood flavor exposure and examine its effects on later nicotine use behaviors. Aims and Methods: We employed a two-bottle choice paradigm in weanling rats to mimic human childhood flavor exposure. Subsequently, we investigated the impact of early exposure to sweet (saccharin) and cherry fruit (benzaldehyde) flavors on adolescent nicotine use behaviors. This included assessing subsequent nicotine acquisition, maintenance, and seeking behaviors using intraoral flavor and intravenous nicotine self-administration. Results: Our findings reveal that rats exposed to saccharin during early development exhibited altered patterns of nicotine intake and seeking behaviors during adolescence. Specifically, rats demonstrated increased nicotine intake and seeking of saccharin flavored solutions when paired with nicotine, indicating a potential predisposition towards nicotine use following childhood flavor exposure. Intraoral benzaldehyde did not affect nicotine reinforcement in early sessions of self-administration, but significantly decreased nicotine reinforcement during later sessions. Both saccharin exposure alone or in combination with benzaldehyde promoted nicotine reinforcement. No significant sex differences in nicotine-related behaviors were observed. Conclusions: This study highlights the significance of early flavor exposure in shaping adolescent nicotine use behaviors. The findings suggest that childhood exposure to sweet flavors may contribute to heightened susceptibility to nicotine use and addiction later in life. Understanding these early influences is crucial for developing targeted interventions to prevent the onset of nicotine addiction during adolescence. Implications: Our study highlights the importance of how sweetness can contribute to and possibly even alter the effects of the flavor itself. The sweetness of a tobacco product does not solely stem from sweeteners, but it is also influenced by other components such as the propylene glycol (PG) and vegetable glycerin (VG) ratio (eg, higher VG) and the inclusion of flavors associated with sweetness (eg, vanillin and ethyl maltol). Therefore, sweet-associated constituents in tobacco products should be investigated further to inform regulatory policy. We believe that our findings can inform regulatory decisions on controlling sweet-associated constituents in tobacco products.
- 16 August 2024
- Published by Elsevier in Current Opinion in Neurobiology
- Vol. 88, 102900
The influence of ovarian hormones on the putative mechanisms that promote female nicotine use
- 16 August 2024
- Published by Elsevier in Current Opinion in Neurobiology
- Vol. 88, 102900
The influence of ovarian hormones on the putative mechanisms that promote female nicotine use
- 6 June 2024
- Published by Springer Nature in Psychopharmacology
- Vol. 241 (11) , 2241-2253
Impact of vanilla flavor on nicotine taste, choice, intake, and seeking behaviors
Rationale Flavors can alter the orosensory properties of tobacco products. Specifically, flavors can serve as an oral cue for smokeless tobacco products. Objectives We aimed to investigate the impact of oral vanillin, the principal chemical of vanilla flavor in tobacco products, on nicotine’s taste, and nicotine choice, intake, and seeking behaviors. Methods Experiments were performed in young adult Sprague Dawley rats. We employed a two-bottle free-choice test (2BC) to measure the preference for different concentrations of vanillin and its effect on nicotine preference. To explore the long-term effects of early exposure to sweetened vanillin, we utilized a combined 2BC and intraoral self-administration (IOSA) model. We assessed the nicotine taking and seeking behaviors in the presence or absence of vanillin. We performed a taste reactivity test (TRT) to quantify liking (ingestive) and disliking (aversive) taste responses to oral nicotine with or without vanillin. Results In 2BC, female rats preferred vanillin containing solutions more than their male counterparts. In IOSA, vanillin alone and in combination with nicotine led to greater IOSA compared to water. Female rats self-administered vanillin plus nicotine more than male rats. Vanillin increased motivation to nicotine taking, but only in females. In TRT, vanillin increased nicotine’s ingestive responses but blocked aversive responses in both sexes. Conclusions These results indicate that vanilla flavor can increase oral nicotine intake. It can also increase liking and decrease disliking of nicotine’s taste. Furthermore, the impact of vanilla flavor on nicotine taste and nicotine choice, intake, and seeking behaviors is concentration and sex dependent.
- 6 June 2024
- Published by Springer Nature in Psychopharmacology
- Vol. 241 (11) , 2241-2253
Impact of vanilla flavor on nicotine taste, choice, intake, and seeking behaviors
Rationale Flavors can alter the orosensory properties of tobacco products. Specifically, flavors can serve as an oral cue for smokeless tobacco products. Objectives We aimed to investigate the impact of oral vanillin, the principal chemical of vanilla flavor in tobacco products, on nicotine’s taste, and nicotine choice, intake, and seeking behaviors. Methods Experiments were performed in young adult Sprague Dawley rats. We employed a two-bottle free-choice test (2BC) to measure the preference for different concentrations of vanillin and its effect on nicotine preference. To explore the long-term effects of early exposure to sweetened vanillin, we utilized a combined 2BC and intraoral self-administration (IOSA) model. We assessed the nicotine taking and seeking behaviors in the presence or absence of vanillin. We performed a taste reactivity test (TRT) to quantify liking (ingestive) and disliking (aversive) taste responses to oral nicotine with or without vanillin. Results In 2BC, female rats preferred vanillin containing solutions more than their male counterparts. In IOSA, vanillin alone and in combination with nicotine led to greater IOSA compared to water. Female rats self-administered vanillin plus nicotine more than male rats. Vanillin increased motivation to nicotine taking, but only in females. In TRT, vanillin increased nicotine’s ingestive responses but blocked aversive responses in both sexes. Conclusions These results indicate that vanilla flavor can increase oral nicotine intake. It can also increase liking and decrease disliking of nicotine’s taste. Furthermore, the impact of vanilla flavor on nicotine taste and nicotine choice, intake, and seeking behaviors is concentration and sex dependent.